173 related articles for article (PubMed ID: 27784048)
1. Efficacy of Topical Sirolimus (Rapamycin) for the Treatment of Microcystic Lymphatic Malformations.
Ivars M; Redondo P
JAMA Dermatol; 2017 Jan; 153(1):103-105. PubMed ID: 27784048
[No Abstract] [Full Text] [Related]
2. Topical sirolimus solution for lingual microcystic lymphatic malformations in children and adults (TOPGUN): study protocol for a multicenter, randomized, assessor-blinded, controlled, stepped-wedge clinical trial.
Marchand A; Caille A; Gissot V; Giraudeau B; Lengelle C; Bourgoin H; Largeau B; Leducq S; Maruani A
Trials; 2022 Jul; 23(1):557. PubMed ID: 35804404
[TBL] [Abstract][Full Text] [Related]
3. Topical rapamycin (sirolimus) for treatment of cutaneous microcystic lymphatic malformation of the gluteal area.
Leducq S; Vrignaud S; Lorette G; Herbreteau D; Dubee V; Martin L; Maruani A
Eur J Dermatol; 2019 Feb; 29(1):82-83. PubMed ID: 30530427
[No Abstract] [Full Text] [Related]
4. Treatment of superficial vascular anomalies with topical sirolimus: A multicenter case series.
Dodds M; Tollefson M; Castelo-Soccio L; Garzon MC; Hogeling M; Hook K; Boull C; Maguiness S
Pediatr Dermatol; 2020 Mar; 37(2):272-277. PubMed ID: 31957126
[TBL] [Abstract][Full Text] [Related]
5. Topical sirolimus 0.1% for treating cutaneous microcystic lymphatic malformations in children and adults (TOPICAL): protocol for a multicenter phase 2, within-person, randomized, double-blind, vehicle-controlled clinical trial.
Leducq S; Caille A; Barbarot S; Bénéton N; Bessis D; Boccara O; Bursztejn AC; Chiaverini C; Dompmartin A; Droitcourt C; Gissot V; Goga D; Guibaud L; Herbreteau D; Le Touze A; Léauté-Labrèze C; Lorette G; Mallet S; Martin L; Mazereeuw-Hautier J; Phan A; Plantin P; Quéré I; Vabres P; Bourgoin H; Giraudeau B; Maruani A;
Trials; 2019 Dec; 20(1):739. PubMed ID: 31847908
[TBL] [Abstract][Full Text] [Related]
6. Topical rapamycin and microcystic lymphatic malformations.
Gu Y; Sebaratnam DF
J Am Acad Dermatol; 2024 Jan; 90(1):e29-e30. PubMed ID: 37717734
[No Abstract] [Full Text] [Related]
7. Use of topical rapamycin in the treatment of superficial lymphatic malformations.
García-Montero P; Del Boz J; Baselga-Torres E; Azaña-Defez JM; Alcaraz-Vera M; Tercedor-Sánchez J; Noguera-Morel L; Vera-Casaño Á
J Am Acad Dermatol; 2019 Feb; 80(2):508-515. PubMed ID: 30296533
[TBL] [Abstract][Full Text] [Related]
8. Topical sirolimus for the treatment of cutaneous manifestations of vascular anomalies: A case series.
Badia P; Ricci K; Gurria JP; Dasgupta R; Patel M; Hammill A
Pediatr Blood Cancer; 2020 Apr; 67(4):e28088. PubMed ID: 31930696
[TBL] [Abstract][Full Text] [Related]
9. Sirolimus is highly effective for lymph leakage in microcystic lymphatic malformations with skin involvement.
Rössler J; Geiger J; Földi E; Adams DM; Niemeyer CM
Int J Dermatol; 2017 Apr; 56(4):e72-e75. PubMed ID: 27706796
[No Abstract] [Full Text] [Related]
10. Generalized lymphatic anomaly successfully treated with long-term, low-dose sirolimus.
Dvorakova V; Rea D; O'Regan GM; Irvine AD
Pediatr Dermatol; 2018 Jul; 35(4):533-534. PubMed ID: 29582448
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and absorption of topical sirolimus for the treatment of vascular anomalies in children: A case series.
Le Sage S; David M; Dubois J; Powell J; McCuaig CC; Théorêt Y; Kleiber N
Pediatr Dermatol; 2018 Jul; 35(4):472-477. PubMed ID: 29790593
[TBL] [Abstract][Full Text] [Related]
12. Topical Tacrolimus 0.1% for treatment of cutaneous microcystic lymphatic malformations.
Salvia SA; Amore MA; Papendieck CM
Lymphology; 2021; 54(2):106-111. PubMed ID: 34735755
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of sirolimus in the treatment of microcystic lymphatic malformation of the tongue.
Ghariani Fetoui N; Boussofara L; Gammoudi R; Belajouza C; Ghariani N; Denguezli M
J Eur Acad Dermatol Venereol; 2019 Sep; 33(9):e336-e337. PubMed ID: 30980684
[No Abstract] [Full Text] [Related]
14. Topical rapamycin in superficial lymphatic malformation: Microcystic lymphatic malformation or verrucous venous malformation?
Cai R; Gu H; Yu Z; Yang X; Chen H; Lin X
J Am Acad Dermatol; 2023 May; 88(5):e267-e268. PubMed ID: 30710605
[No Abstract] [Full Text] [Related]
15. Treatment of Lymphatic Malformations with the mTOR Inhibitor Sirolimus: A Systematic Review.
Wiegand S; Wichmann G; Dietz A
Lymphat Res Biol; 2018 Aug; 16(4):330-339. PubMed ID: 29924669
[TBL] [Abstract][Full Text] [Related]
16. Oral Sirolimus: An Option in the Management of Neonates with Life-Threatening Upper Airway Lymphatic Malformations.
Triana P; Miguel M; Díaz M; Cabrera M; López Gutiérrez JC
Lymphat Res Biol; 2019 Oct; 17(5):504-511. PubMed ID: 30985248
[No Abstract] [Full Text] [Related]
17. Sirolimus as treatment for 19 patients with refractory cervicofacial lymphatic malformation.
Strychowsky JE; Rahbar R; O'Hare MJ; Irace AL; Padua H; Trenor CC
Laryngoscope; 2018 Jan; 128(1):269-276. PubMed ID: 28782106
[TBL] [Abstract][Full Text] [Related]
18. Microcystic Lymphatic Malformation Successfully Treated With Topical Rapamycin.
García-Montero P; Del Boz J; Sanchez-Martínez M; Escudero Santos IM; Baselga E
Pediatrics; 2017 May; 139(5):. PubMed ID: 28557723
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Initial Sirolimus Therapy for 27 Patients with Intractable Lymphatic Malformations.
Zhang X; Wang S; Guo Y; Liu Y; Zhang J; Li Y; Liu Q; Liu Z; Sun N; Li X; Liu Y; Du J; Cheng X; Wang X; Tai J; Ni X
Laryngoscope; 2021 Aug; 131(8):1902-1908. PubMed ID: 33571378
[TBL] [Abstract][Full Text] [Related]
20. Treatment With Topical Sirolimus for Recurrent Lymphatic Malformation of the External Urethral Meatus.
Yonekura S; Komori T; Ishida Y; Kogame T; Kabashima K
JAMA Dermatol; 2022 Nov; 158(11):1331-1332. PubMed ID: 36044195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
